Research Article
TRAF1/C5 but Not PTPRC Variants Are Potential Predictors of Rheumatoid Arthritis Response to Anti-Tumor Necrosis Factor Therapy
Table 1
Baseline demographic and clinical characteristics of the 383 rheumatoid arthritis patients treated with anti-TNF drugs.
| ||||||||||||||||||||||||||||||||||||||||||
Values shown are means (SD) or (%). TNF: tumor necrosis factor; ACPA: anticitrullinated peptides antibodies; DMARDs: disease modifying antirheumatic drugs; MTX: methotrexate; DAS: disease activity score; ESR: erythrocyte sedimentation rate. |